130 results
Page 5 of 7
F-4
72ci1du
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
wexypmu1
7 Jun 21
Prospectus supplement
9:16am
424B3
zhgndxzj5zhyf136g0
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
hpa2uh1a
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
841 ni3ccl
3 Jun 21
Prospectus supplement
6:06am
424B3
lhgtpheijwsz3igz2
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
z8jrzp
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
g7t gk8zplv81uxg3vg
2 Jun 21
Prospectus supplement
10:10am
424B3
qtb9dweoxfv8i
2 Jun 21
Prospectus supplement
10:09am
424B3
4x4cse59
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
9epjr eyeo
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
o0iqiwp hdvmv
5 May 21
Business combination disclosure
5:27pm
425
djel2
5 May 21
Business combination disclosure
5:26pm
425
k4vjpmjx enkc
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
nxk1czgzc6ezy xf
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
bd3si 9wr2g
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
tg7mbmudyb4w3d
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
3y5wz
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
gidm9bdhlqshpaixh7
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
lixpp6pgy9vnsbfaddj
30 Apr 21
Annual report (foreign)
12:53pm